Furthermore, overactivity of the calmodulin-dependent kinase II (CaMKII) pathway may contribute to CPVT in individuals carrying an RyR2 variant [78]. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.